The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma
Since the establishment of the Milan criteria, liver transplantation (LT) has been identified as an optimal therapy for selected patients with early stage, unresectable hepatocellular carcinoma (HCC) complicating cirrhosis, although a major limitation is the critical shortage of available deceased donor liver allografts. This review focuses on the evolution of liver allocation for HCC in the United States and what the most recent revisions to the allocation system mean for patients with HCC.
Source: Clinics in Liver Disease - Category: Gastroenterology Authors: Lavanya Yohanathan, Julie K. Heimbach Source Type: research
More News: Bone Graft | Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Transplants | Urology & Nephrology | USA Health